Patient support

Find out about the support systems in place for Zavesca patients.

Learn more

FAQ

What should you know about taking Zavesca? Find answers to your most common questions here.

Learn more

Zavesca patient stories

In this video, you'll meet three patients with type 1 Gaucher disease who are taking Zavesca therapy. Listen as they share their stories and learn more about what you can do to better understand and manage this disease.

Read frequently asked questions (FAQ) about Zavesca

What is ZAVESCA?

ZAVESCA is a prescription medicine taken by mouth for adults with mild to moderate type 1 Gaucher disease. ZAVESCA is used only in people who cannot be treated with enzyme replacement therapy.

Important Safety Information for Zavesca:

In clinical studies, the most common adverse events due to Zavesca included weight loss, diarrhea, and trembling in the hand (tremor). Other common adverse reactions were excess gas (flatulence), abdominal pain, and headache. The most common serious adverse reaction was tingling or numbness in the hands or feet with or without pain (peripheral neuropathy). Patients should undergo neurological examination at the start of treatment and every 6 months thereafter; Zavesca should be reassessed in patients who develop symptoms of peripheral neuropathy. Zavesca may cause fetal harm if administered to a pregnant woman. Men should maintain reliable contraceptive methods and not plan to father a child while taking Zavesca and for 3 months after discontinuing treatment.

Please see full Prescribing Information.